Ticlopidine hydrochloride (Apotex Corp.)


Welcome to the PulseAid listing for the Ticlopidine hydrochloride drug offered from Apotex Corp.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotex Corp.
NON-PROPRIETARY NAME: Ticlopidine hydrochloride
SUBSTANCE NAME: TICLOPIDINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1999-07-01
END MARKETING DATE: 0000-00-00


Ticlopidine hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTiclopidine hydrochloride from Apotex Corp.
LABELER NAME: Apotex Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1999-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60505-0027_072b86f7-4a22-d3b2-ca03-8edd6bc1c128
PRODUCT NDC: 60505-0027
APPLICATION NUMBER: ANDA075089

Other TICLOPIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Ticlopidine hydrochloride
Caraco Pharmaceutical Laboratories, Ltd.Ticlopidine Hydrochloride
Carilion Materials ManagementTiclopidine Hydrochloride
Eon Labs, Inc.Ticlopidine Hydrochloride